Making medicines affordable in India
25th février 2020
After nearly 10 years of operations, the Medicines Patent Pool (MPP) went to India to see first-hand how access to quality-assured generic medicines for HIV and hepatitis C has changed people’s life. In the first of our impact series videos, patients, medical experts, governments, among others, explain how MPP’s work has generated impact. From saving lives to increased access, originators, generic manufacturers and committed partners have worked with MPP to deliver the best quality treatments to those who need them most.
Negotiating public-health driven licences with patent holders and sublicensing to generic manufacturers and product developers is the core work of the Medicines Patent Pool.
About the Medicines Patent Pool
The Medicines Patent Pool is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. To date, MPP has signed agreements with ten patent holders for thirteen HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals and a tuberculosis treatment. MPP was founded by Unitaid which serves as sole funder for MPP’s activities in HIV, hepatitis C and tuberculosis.